{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:18:29Z","timestamp":1778156309771,"version":"3.51.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ovarian cancer has a poor clinical prognosis due to chemoresistance following carboplatin\/paclitaxel treatment. This phenomenon can be explained by an imbalanced ratio of [anti-apoptotic (BCL-xL\/MCL-1)] to [pro-apoptotic (Noxa, BIM, PUMA)] BCL-2 family members that prevents apoptosis initiation. Consequently, any treatment capable of counterbalancing this ratio could be beneficial in the management of ovarian cancer. Calcium signaling is strongly implicated in resistance to apoptosis, as it depends on, but also regulates, the expression of the ratio of BCL-2 family members, making calcium-targeted strategies relevant to overcoming chemoresistance. Knowing that SERCA2 calcium pumps regulation plays a major role in controlling the ER stress-induced UPR response that could lead to pro-apoptotic protein upregulation and cell death, we therefore evaluated whether their inhibition could elicit apoptosis or sensitize ovarian cancer cells to other therapeutic strategies. For this purpose, the platinum-resistant cell line, OAW42-R, was treated with anti-SERCA2 strategies which revert the BCL-2 family member expression ratio in favor of pro-apoptotic proteins. Combination with the BH3-mimetic ABT-737 exacerbates this imbalance not only by inhibiting BCL-xL activity but also through over-induction of the UPR\/ATF4\/Noxa axis, leading to MCL-1 inhibition. This dual effect of ABT-737 upon ER stress fully suppresses the anti-apoptotic capacities of cancer cells, leading to massive mitochondrial apoptosis. This point was supported with ONC201, the first member of the imipridone family of anticancer drugs to enter the clinic, whose ability to trigger UPR\/ATF4\/Noxa led to apoptosis commitment when it was combined with ABT-737 treatment. The therapeutic efficacy of these combinations was also proved in patient-derived tumor organoid models (PDTO), leading to their structural disintegration and reduced viability. Collectively, our study highlights that ABT-737, through BCL-xL inhibition and synergy with ER stress inducers, triggers ovarian cancer death, offering promising strategies for overcoming chemoresistance in relapsed ovarian cancer.<\/jats:p>","DOI":"10.1038\/s41419-026-08559-7","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:08:42Z","timestamp":1774631322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["UPR\/ATF4\/Noxa pathway overactivation through SERCA2 inhibition or ONC201 treatment combined with ABT-737 triggers apoptosis in chemoresistant ovarian cancer cells and patient-derived tumor organoids"],"prefix":"10.1038","volume":"17","author":[{"given":"Sahra","family":"Messaoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romane","family":"Florent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6935-100X","authenticated-orcid":false,"given":"Louis-Bastien","family":"Weiswald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Desmartin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Lecouflet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Lohard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Grunchec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwige","family":"Abeilard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyne","family":"Guillamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordane","family":"Divoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Goudergues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Brotin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enora","family":"Dolivet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8867-0778","authenticated-orcid":false,"given":"Monique","family":"N\u2019Diaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"8559_CR1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156:1336\u201346.","journal-title":"Int J Cancer"},{"key":"8559_CR2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","volume":"20","author":"AC Veneziani","year":"2023","unstructured":"Veneziani AC, Gonzalez-Ochoa E, Alqaisi H, Madariaga A, Bhat G, Rouzbahman M, et al. Heterogeneity and treatment landscape of ovarian carcinoma. Nat Rev Clin Oncol. 2023;20:820\u201342.","journal-title":"Nat Rev Clin Oncol"},{"key":"8559_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ijc.24787","volume":"126","author":"E Brotin","year":"2010","unstructured":"Brotin E, Meryet-Figuiere M, Simonin K, Duval RE, Villedieu M, Leroy-Dudal J, et al. Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis. Int J Cancer. 2010;126:885\u201395.","journal-title":"Int J Cancer"},{"key":"8559_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102771","volume":"129","author":"D Del Bufalo","year":"2024","unstructured":"Del Bufalo D, Damia G. Overview of BH3 mimetics in ovarian cancer. Cancer Treat Rev. 2024;129:102771.","journal-title":"Cancer Treat Rev"},{"key":"8559_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","volume":"10","author":"M Vogler","year":"2025","unstructured":"Vogler M, Braun Y, Smith VM, Westhoff M-A, Pereira RS, Pieper NM, et al. The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy. Signal Transduct Target Ther. 2025;10:91.","journal-title":"Signal Transduct Target Ther"},{"key":"8559_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","volume":"10","author":"MF van Delft","year":"2006","unstructured":"van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE, et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized. Cancer Cell. 2006;10:389\u201399.","journal-title":"Cancer Cell"},{"key":"8559_CR7","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1158\/1535-7163.MCT-09-0493","volume":"8","author":"K Simonin","year":"2009","unstructured":"Simonin K, Brotin E, Dufort S, Dutoit S, Goux D, N\u2019diaye M, et al. Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells. Mol Cancer Ther. 2009;8:3162\u201370.","journal-title":"Mol Cancer Ther"},{"key":"8559_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s10495-012-0799-x","volume":"18","author":"K Simonin","year":"2013","unstructured":"Simonin K, N\u2019diaye M, Lheureux S, Loussouarn C, Dutoit S, Briand M, et al. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1\/Noxa axis. Apoptosis. 2013;18:492\u2013508.","journal-title":"Apoptosis"},{"key":"8559_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","volume":"22","author":"ST Diepstraten","year":"2022","unstructured":"Diepstraten ST, Anderson MA, Czabotar PE, Lessene G, Strasser A, Kelly GL. The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs. Nat Rev Cancer. 2022;22:45\u201364.","journal-title":"Nat Rev Cancer"},{"key":"8559_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1158\/1535-7163.MCT-16-0342","volume":"16","author":"C Petigny-Lechartier","year":"2017","unstructured":"Petigny-Lechartier C, Duboc C, Jebahi A, Louis MH, Abeilard E, Denoyelle C, et al. The mTORC1\/2 inhibitor AZD8055 strengthens the efficiency of the MEK inhibitor trametinib to reduce the Mcl-1\/[Bim and Puma] ratio and to sensitize ovarian carcinoma cells to ABT-737. Mol Cancer Ther. 2017;16:102\u201315.","journal-title":"Mol Cancer Ther"},{"key":"8559_CR11","first-page":"367","volume":"17","author":"GR Monteith","year":"2017","unstructured":"Monteith GR, Prevarskaya N, Roberts-Thomson SJ. The calcium-cancer signalling nexus. NatRevCancer. 2017;17:367\u201380.","journal-title":"NatRevCancer"},{"key":"8559_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1152\/physrev.00044.2016","volume":"98","author":"N Prevarskaya","year":"2018","unstructured":"Prevarskaya N, Skryma R, Shuba Y. Ion channels in cancer: are cancer hallmarks oncochannelopathies? Physiol Rev. 2018;98:559\u2013621.","journal-title":"Physiol Rev"},{"key":"8559_CR13","doi-asserted-by":"publisher","first-page":"20130097","DOI":"10.1098\/rstb.2013.0097","volume":"369","author":"N Prevarskaya","year":"2014","unstructured":"Prevarskaya N, Ouadid-Ahidouch H, Skryma R, Shuba Y. Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks?. Philos Trans R Soc Lond B Biol Sci. 2014;369:20130097.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"8559_CR14","doi-asserted-by":"publisher","first-page":"33896","DOI":"10.18632\/oncotarget.26084","volume":"9","author":"M-L Bonnefond","year":"2018","unstructured":"Bonnefond M-L, Florent R, Lenoir S, Lambert B, Abeilard E, Giffard F, et al. Inhibition of store-operated channels by carboxyamidotriazole sensitizes ovarian carcinoma cells to anti-BclxL strategies through Mcl-1 down-regulation. Oncotarget. 2018;9:33896\u2013911.","journal-title":"Oncotarget"},{"key":"8559_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10495-015-1095-3","volume":"20","author":"ML Bonnefond","year":"2015","unstructured":"Bonnefond ML, Lambert B, Giffard F, Abeilard E, Brotin E, Louis MH, et al. Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation. Apoptosis. 2015;20:535\u201350.","journal-title":"Apoptosis"},{"key":"8559_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ijms22010004","volume":"22","author":"A Jaskulska","year":"2020","unstructured":"Jaskulska A, Janecka AE, Gach-Janczak K. Thapsigargin-from traditional medicine to anticancer drug. Int J Mol Sci. 2020;22:4.","journal-title":"Int J Mol Sci"},{"key":"8559_CR17","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.3390\/molecules26247469","volume":"26","author":"JT Isaacs","year":"2021","unstructured":"Isaacs JT, Brennen WN, Christensen SB, Denmeade SR. Mipsagargin: the beginning-not the end-of thapsigargin prodrug-based cancer therapeutics. Molecules. 2021;26:7469.","journal-title":"Molecules"},{"key":"8559_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ceca.2017.07.001","volume":"69","author":"ER Chemaly","year":"2018","unstructured":"Chemaly ER, Troncone L, Lebeche D. SERCA control of cell death and survival. Cell Calcium. 2018;69:46\u201361.","journal-title":"Cell Calcium"},{"key":"8559_CR19","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka K, Koryga I, Mnich K, Ljujic M, Samali A, Gorman AM. The integrated stress response. EMBO Rep. 2016;17:1374\u201395.","journal-title":"EMBO Rep"},{"key":"8559_CR20","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/cdd.2017.82","volume":"24","author":"P Pih\u00e1n","year":"2017","unstructured":"Pih\u00e1n P, Carreras-Sureda A, Hetz C. BCL-2 family: integrating stress responses at the ER to control cell demise. Cell Death Differ. 2017;24:1478\u201387.","journal-title":"Cell Death Differ"},{"key":"8559_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep35196","volume":"6","author":"Z Ma","year":"2016","unstructured":"Ma Z, Fan C, Yang Y, Di S, Hu W, Li T, et al. Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation. Sci Rep. 2016;6:35196.","journal-title":"Sci Rep"},{"key":"8559_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1158\/1535-7163.MCT-10-0812","volume":"10","author":"L Wang","year":"2011","unstructured":"Wang L, Wang L, Song R, Shen Y, Sun Y, Gu Y, et al. Targeting sarcoplasmic\/endoplasmic reticulum Ca2+-ATPase 2 by curcumin induces ER stress-associated apoptosis for treating human liposarcoma. Mol Cancer Ther. 2011;10:461\u201371.","journal-title":"Mol Cancer Ther"},{"key":"8559_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.538","volume":"5","author":"W Li","year":"2014","unstructured":"Li W, Ouyang Z, Zhang Q, Wang L, Shen Y, Wu X, et al. SBF-1 exerts strong anticervical cancer effect through inducing endoplasmic reticulum stress-associated cell death via targeting sarco\/endoplasmic reticulum Ca(2+)-ATPase 2. Cell Death Dis. 2014;5:e1581.","journal-title":"Cell Death Dis"},{"key":"8559_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2588-8","volume":"11","author":"R Florent","year":"2020","unstructured":"Florent R, Weiswald L-B, Lambert B, Brotin E, Abeilard E, Louis M-H, et al. Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib. Cell Death Dis. 2020;11:380.","journal-title":"Cell Death Dis"},{"key":"8559_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ygyno.2008.11.028","volume":"112","author":"K McLean","year":"2009","unstructured":"McLean K, VanDeVen NA, Sorenson DR, Daudi S, Liu JR. The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells. Gynecol Oncol. 2009;112:623\u201330.","journal-title":"Gynecol Oncol"},{"key":"8559_CR26","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1158\/1078-0432.CCR-14-0553","volume":"20","author":"JY Yoo","year":"2014","unstructured":"Yoo JY, Hurwitz BS, Bolyard C, Yu J-G, Zhang J, Selvendiran K, et al. Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects. Clin Cancer Res J Am Assoc Cancer Res. 2014;20:3787\u201398.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"8559_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","volume":"22","author":"VV Prabhu","year":"2020","unstructured":"Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, et al. ONC201 and imipridones: anti-cancer compounds with clinical efficacy. Neoplasia. 2020;22:725\u201344.","journal-title":"Neoplasia"},{"key":"8559_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.789450","volume":"12","author":"Y Fan","year":"2022","unstructured":"Fan Y, Wang J, Fang Z, Pierce SR, West L, Staley A, et al. Anti-tumor and anti-invasive effects of ONC201 on ovarian cancer cells and a transgenic mouse model of serous ovarian cancer. Front Oncol. 2022;12:789450.","journal-title":"Front Oncol"},{"key":"8559_CR29","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1002\/cam4.3858","volume":"10","author":"M Rumman","year":"2021","unstructured":"Rumman M, Buck S, Polin L, Dzinic S, Boerner J, Winer IS. ONC201 induces the unfolded protein response (UPR) in high- and low-grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity. Cancer Med. 2021;10:3373\u201387.","journal-title":"Cancer Med"},{"key":"8559_CR30","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1093\/neuonc\/noae031","volume":"26","author":"I Arrillaga-Romany","year":"2024","unstructured":"Arrillaga-Romany I, Lassman A, McGovern SL, Mueller S, Nabors B, van den Bent M, et al. ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro-Oncol. 2024;26:S173\u201381.","journal-title":"Neuro-Oncol"},{"key":"8559_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00952-5","volume":"13","author":"BM Barnes","year":"2021","unstructured":"Barnes BM, Nelson L, Tighe A, Burghel GJ, Lin I-H, Desai S, et al. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes. Genome Med. 2021;13:140.","journal-title":"Genome Med"},{"key":"8559_CR32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/(SICI)1097-0215(19981109)78:4<454::AID-IJC11>3.0.CO;2-6","volume":"78","author":"L Poulain","year":"1998","unstructured":"Poulain L, Lincet H, Duigou F, Deslandes E, Sichel F, Gauduchon P, et al. Acquisition of chemoresistance in a human ovarian carcinoma cell is linked to a defect in cell cycle control. Int J Cancer. 1998;78:454\u201363.","journal-title":"Int J Cancer"},{"key":"8559_CR33","doi-asserted-by":"publisher","first-page":"282.","DOI":"10.1186\/s13046-025-03537-x","volume":"44","author":"L Thorel","year":"2025","unstructured":"Thorel L, Dolivet E, Morice PM, Florent R, Divoux J, Perr\u00e9ard M, et al. Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response. J Exp Clin Cancer Res. 2025;44:282.","journal-title":"J Exp Clin Cancer Res"},{"key":"8559_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12429-w","volume":"24","author":"L Thorel","year":"2024","unstructured":"Thorel L, Divoux J, Lequesne J, Babin G, Morice P-M, Florent R, et al. The OVAREX study: establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers. BMC Cancer. 2024;24:701.","journal-title":"BMC Cancer"},{"key":"8559_CR35","doi-asserted-by":"publisher","first-page":"10775","DOI":"10.1073\/pnas.0902295106","volume":"106","author":"K Mahn","year":"2009","unstructured":"Mahn K, Hirst SJ, Ying S, Holt MR, Lavender P, Ojo OO, et al. Diminished sarco\/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma. Proc Natl Acad Sci USA. 2009;106:10775\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8559_CR36","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1111\/febs.13598","volume":"283","author":"R Iurlaro","year":"2016","unstructured":"Iurlaro R, Mu\u00f1oz-Pinedo C. Cell death induced by endoplasmic reticulum stress. FEBS J. 2016;283:2640\u201352.","journal-title":"FEBS J"},{"key":"8559_CR37","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.tem.2017.07.003","volume":"28","author":"IMN Wortel","year":"2017","unstructured":"Wortel IMN, van der Meer LT, Kilberg MS, van Leeuwen FN. Surviving stress: modulation of ATF4-mediated stress responses in normal and malignant cells. Trends Endocrinol Metab TEM. 2017;28:794\u2013806.","journal-title":"Trends Endocrinol Metab TEM"},{"key":"8559_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke S, Sinha R, Levine DA, Sander C, Schultz N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun. 2013;4:2126.","journal-title":"Nat Commun"},{"key":"8559_CR39","first-page":"307","volume":"13","author":"FR Di Cristofano","year":"2023","unstructured":"Di Cristofano FR, Fong MW, Huntington KE, Carneiro BA, Zhou L, El-Deiry WS. Synergistic activity of ABT-263 and ONC201\/TIC10 against solid tumor cell lines is associated with suppression of anti-apoptotic Mcl-1, BAG3, pAkt, and upregulation of pro-apoptotic Noxa and Bax cleavage during apoptosis. Am J Cancer Res. 2023;13:307\u201325.","journal-title":"Am J Cancer Res"},{"key":"8559_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174698","volume":"915","author":"LA Bertocci","year":"2022","unstructured":"Bertocci LA, Rovatti JR, Wu A, Morey A, Bose DD, Kinney SRM. Calcium handling genes are regulated by promoter DNA methylation in colorectal cancer cells. Eur J Pharm. 2022;915:174698.","journal-title":"Eur J Pharm"},{"key":"8559_CR41","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1111\/febs.12064","volume":"280","author":"A Arbabian","year":"2013","unstructured":"Arbabian A, Brouland J-P, Ap\u00e1ti \u00c1, P\u00e1szty K, Heged\u0171s L, Enyedi \u00c1, et al. Modulation of endoplasmic reticulum calcium pump expression during lung cancer cell differentiation. FEBS J. 2013;280:5408\u201318.","journal-title":"FEBS J"},{"key":"8559_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9359879","volume":"2022","author":"J Li","year":"2022","unstructured":"Li J, Li X, Huang H, Tao L, Zhang C, Xie Y, et al. Role of SERCA3 in the prognosis and immune function in pan-cancer. J Oncol. 2022;2022:9359879.","journal-title":"J Oncol"},{"key":"8559_CR43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.fitote.2015.12.005","volume":"109","author":"LS Einbond","year":"2016","unstructured":"Einbond LS, Wu H, Sandu C, Ford M, Mighty J, Antonetti V, et al. Digitoxin enhances the growth inhibitory effects of thapsigargin and simvastatin on ER negative human breast cancer cells. Fitoterapia. 2016;109:146\u201354.","journal-title":"Fitoterapia"},{"key":"8559_CR44","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1007\/s00432-022-04129-4","volume":"148","author":"Y Bellizzi","year":"2022","unstructured":"Bellizzi Y, Cornier PG, Delpiccolo CML, Mata EG, Blank V, Roguin LP. Synergistic antitumor effect of a penicillin derivative combined with thapsigargin in melanoma cells. J Cancer Res Clin Oncol. 2022;148:3361\u201373.","journal-title":"J Cancer Res Clin Oncol"},{"key":"8559_CR45","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/cells11040641","volume":"11","author":"Y-C Chen","year":"2022","unstructured":"Chen Y-C, Yang C-W, Chan T-F, Farooqi AA, Chang H-S, Yen C-H, et al. Cryptocaryone promotes ROS-dependent antiproliferation and apoptosis in ovarian cancer cells. Cells. 2022;11:641.","journal-title":"Cells"},{"key":"8559_CR46","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1021\/jm500672y","volume":"58","author":"Gloaguen","year":"2015","unstructured":"Gloaguen, Voisin-Chiret C, Sopkova-de AS, Oliveira SJ, Fogha J, Gautier F, et al. First evidence that oligopyridines, alpha-helix foldamers, inhibit Mcl-1 and sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies. J Med Chem. 2015;58:1644\u201368.","journal-title":"J Med Chem"},{"key":"8559_CR47","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.2147\/DDDT.S209947","volume":"13","author":"L Wu","year":"2019","unstructured":"Wu L, Huang X, Kuang Y, Xing Z, Deng X, Luo Z. Thapsigargin induces apoptosis in adrenocortical carcinoma by activating endoplasmic reticulum stress and the JNK signaling pathway: an in vitro and in vivo study. Drug Des Dev Ther. 2019;13:2787\u201398.","journal-title":"Drug Des Dev Ther"},{"key":"8559_CR48","doi-asserted-by":"publisher","first-page":"19656","DOI":"10.1074\/jbc.M117.796920","volume":"292","author":"P Sehgal","year":"2017","unstructured":"Sehgal P, Szalai P, Olesen C, Praetorius HA, Nissen P, Christensen SB, et al. Inhibition of the sarco\/endoplasmic reticulum (ER) Ca2+-ATPase by thapsigargin analogs induces cell death via ER Ca2+ depletion and the unfolded protein response. J Biol Chem. 2017;292:19656\u201373.","journal-title":"J Biol Chem"},{"key":"8559_CR49","volume":"2014","author":"F Wang","year":"2014","unstructured":"Wang F, Liu D, Xu H, Li Y, Wang W, Liu B, et al. Thapsigargin induces apoptosis by impairing cytoskeleton dynamics in human lung adenocarcinoma cells. ScientificWorldJournal. 2014;2014:619050.","journal-title":"ScientificWorldJournal"},{"key":"8559_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12964-019-0499-z","volume":"18","author":"P Lindner","year":"2020","unstructured":"Lindner P, Christensen SB, Nissen P, M\u00f8ller JV, Engedal N. Cell death induced by the ER stressor thapsigargin involves death receptor 5, a non-autophagic function of MAP1LC3B, and distinct contributions from unfolded protein response components. Cell Commun Signal CCS. 2020;18:12.","journal-title":"Cell Commun Signal CCS"},{"key":"8559_CR51","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.cell.2007.04.027","volume":"129","author":"H Puthalakath","year":"2007","unstructured":"Puthalakath H, O\u2019Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND, et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell. 2007;129:1337\u201349.","journal-title":"Cell"},{"key":"8559_CR52","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/cdd.2010.152","volume":"18","author":"L Zhang","year":"2011","unstructured":"Zhang L, Lopez H, George NM, Liu X, Pang X, Luo X. Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways. Cell Death Differ. 2011;18:864\u201373.","journal-title":"Cell Death Differ"},{"key":"8559_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0164-7","volume":"9","author":"A Cano-Gonz\u00e1lez","year":"2018","unstructured":"Cano-Gonz\u00e1lez A, Mauro-Lizcano M, Iglesias-Serret D, Gil J, L\u00f3pez-Rivas A. Involvement of both caspase-8 and Noxa-activated pathways in endoplasmic reticulum stress-induced apoptosis in triple-negative breast tumor cells. Cell Death Dis. 2018;9:134.","journal-title":"Cell Death Dis"},{"key":"8559_CR54","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.canlet.2016.09.030","volume":"383","author":"P Gomez-Bougie","year":"2016","unstructured":"Gomez-Bougie P, Halliez M, Moreau P, Pellat-Deceunynck C, Amiot M. Repression of Mcl-1 and disruption of the Mcl-1\/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis. Cancer Lett. 2016;383:204\u201311.","journal-title":"Cancer Lett"},{"key":"8559_CR55","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1074\/jbc.M509868200","volume":"281","author":"J Li","year":"2006","unstructured":"Li J, Lee B, Lee AS. Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J Biol Chem. 2006;281:7260\u201370.","journal-title":"J Biol Chem"},{"key":"8559_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10495-013-0910-y","volume":"19","author":"R Soderquist","year":"2014","unstructured":"Soderquist R, Pletnev AA, Danilov AV, Eastman A. The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA. Apoptosis. 2014;19:201\u20139.","journal-title":"Apoptosis"},{"key":"8559_CR57","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1111\/febs.16346","volume":"289","author":"D Sakthivel","year":"2022","unstructured":"Sakthivel D, Bol\u00edvar BE, Bouchier-Hayes L. Cellular autophagy, an unbidden effect of caspase inhibition by zVAD-fmk. FEBS J. 2022;289:3097\u2013100.","journal-title":"FEBS J"},{"key":"8559_CR58","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.3390\/ijms20235896","volume":"20","author":"A Kishino","year":"2019","unstructured":"Kishino A, Hayashi K, Maeda M, Jike T, Hidai C, Nomura Y, et al. Caspase-8 regulates endoplasmic reticulum stress-induced necroptosis independent of the apoptosis pathway in auditory cells. Int J Mol Sci. 2019;20:5896.","journal-title":"Int J Mol Sci"},{"key":"8559_CR59","doi-asserted-by":"publisher","first-page":"e52483","DOI":"10.1371\/journal.pone.0052483","volume":"7","author":"H Wang","year":"2012","unstructured":"Wang H, Yang Y-B, Shen H-M, Gu J, Li T, Li X-M. ABT-737 induces Bim expression via JNK signaling pathway and its effect on the radiation sensitivity of HeLa cells. PLoS ONE. 2012;7:e52483.","journal-title":"PLoS ONE"},{"key":"8559_CR60","doi-asserted-by":"publisher","first-page":"e2083","DOI":"10.1038\/cddis.2015.400","volume":"7","author":"PJ Le","year":"2016","unstructured":"Le PJ, Maillet L, Sarosiek K, Vuillier C, Gautier F, Montessuit S, et al. Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL. Cell Death Dis. 2016;7:e2083.","journal-title":"Cell Death Dis"},{"key":"8559_CR61","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1182\/blood-2011-01-327197","volume":"118","author":"AA Morales","year":"2011","unstructured":"Morales AA, Kurtoglu M, Matulis SM, Liu J, Siefker D, Gutman DM, et al. Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL\/Bcl-2 in Mcl-1-expressing myeloma cells. Blood. 2011;118:1329\u201339.","journal-title":"Blood"},{"key":"8559_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.379","volume":"5","author":"P Geserick","year":"2014","unstructured":"Geserick P, Wang J, Feoktistova M, Leverkus M. The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin. Cell Death Dis. 2014;5:e1412.","journal-title":"Cell Death Dis"},{"key":"8559_CR63","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-11-1440","volume":"18","author":"JM Tromp","year":"2012","unstructured":"Tromp JM, Geest CR, Breij EC, Elias JA, van LJ, Luijks DM, et al. Tipping the Noxa\/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia. Clin Cancer Res. 2012;18:487\u201398.","journal-title":"Clin Cancer Res"},{"key":"8559_CR64","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/febs.15480","volume":"288","author":"S N\u00fa\u00f1ez-V\u00e1zquez","year":"2021","unstructured":"N\u00fa\u00f1ez-V\u00e1zquez S, S\u00e1nchez-Vera I, Saura-Esteller J, Cosialls AM, Noisier AFM, Albericio F, et al. NOXA upregulation by the prohibitin-binding compound fluorizoline is transcriptionally regulated by integrated stress response-induced ATF3 and ATF4. FEBS J. 2021;288:1271\u201385.","journal-title":"FEBS J"},{"key":"8559_CR65","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/1878-0261.12172","volume":"12","author":"K Sharma","year":"2018","unstructured":"Sharma K, Vu T-T, Cook W, Naseri M, Zhan K, Nakajima W, et al. p53-independent Noxa induction by cisplatin is regulated by ATF3\/ATF4 in head and neck squamous cell carcinoma cells. Mol Oncol. 2018;12:788\u201398.","journal-title":"Mol Oncol"},{"key":"8559_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.281","volume":"5","author":"J Yan","year":"2014","unstructured":"Yan J, Zhong N, Liu G, Chen K, Liu X, Su L, et al. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells. Cell Death Dis. 2014;5:e1316.","journal-title":"Cell Death Dis"},{"key":"8559_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-024-02112-1","volume":"10","author":"R Gadet","year":"2024","unstructured":"Gadet R, Jabbour L, Nguyen TTM, Lohez O, Mikaelian I, Gonzalo P, et al. The endoplasmic reticulum pool of Bcl-xL prevents cell death through IP3R-dependent calcium release. Cell Death Discov. 2024;10:1\u201311.","journal-title":"Cell Death Discov"},{"key":"8559_CR68","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41418-021-00894-w","volume":"29","author":"N Rosa","year":"2022","unstructured":"Rosa N, Ivanova H, Wagner LE, Kale J, La Rovere R, Welkenhuyzen K, et al. Bcl-xL acts as an inhibitor of IP3R channels, thereby antagonizing Ca2+-driven apoptosis. Cell Death Differ. 2022;29:788\u2013805.","journal-title":"Cell Death Differ"},{"key":"8559_CR69","first-page":"E1953","volume":"113","author":"J Yang","year":"2016","unstructured":"Yang J, Vais H, Gu W, Foskett JK. Biphasic regulation of InsP3 receptor gating by dual Ca2+ release channel BH3-like domains mediates Bcl-xL control of cell viability. Proc Natl Acad Sci USA. 2016;113:E1953\u20131962.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8559_CR70","doi-asserted-by":"publisher","first-page":"24882","DOI":"10.1074\/jbc.M111.255828","volume":"286","author":"TC Albershardt","year":"2011","unstructured":"Albershardt TC, Salerni BL, Soderquist RS, Bates DJ, Pletnev AA, Kisselev AF, et al. Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA. J Biol Chem. 2011;286:24882\u201395.","journal-title":"J Biol Chem"},{"key":"8559_CR71","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1111\/jcmm.12913","volume":"20","author":"B Zhang","year":"2016","unstructured":"Zhang B, Yan Y, Li Y, Zhang D, Zeng J, Wang L, et al. Dimethyl celecoxib sensitizes gastric cancer cells to ABT-737 via AIF nuclear translocation. J Cell Mol Med. 2016;20:2148\u201359.","journal-title":"J Cell Mol Med"},{"key":"8559_CR72","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1158\/1535-7163.MCT-13-0998","volume":"13","author":"A Antignani","year":"2014","unstructured":"Antignani A, Sarnovsky R, FitzGerald DJ. ABT-737 promotes the dislocation of ER luminal proteins to the cytosol, including pseudomonas exotoxin. Mol Cancer Ther. 2014;13:1655\u201363.","journal-title":"Mol Cancer Ther"},{"key":"8559_CR73","first-page":"748","volume":"20","author":"T Yan","year":"2023","unstructured":"Yan T, Ma X, Guo L, Lu R. Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy. Cancer Biol Med. 2023;20:748\u201364.","journal-title":"Cancer Biol Med"},{"key":"8559_CR74","doi-asserted-by":"publisher","first-page":"ra18","DOI":"10.1126\/scisignal.aac4374","volume":"9","author":"CLB Kline","year":"2016","unstructured":"Kline CLB, Van den Heuvel APJ, Allen JE, Prabhu VV, Dicker DT, El-Deiry WS. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2\u03b1 kinases. Sci Signal. 2016;9:ra18.","journal-title":"Sci Signal"},{"key":"8559_CR75","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.neo.2017.07.009","volume":"19","author":"Y-S Tu","year":"2017","unstructured":"Tu Y-S, He J, Liu H, Lee HC, Wang H, Ishizawa J, et al. The imipridone ONC201 induces apoptosis and overcomes chemotherapy resistance by up-regulation of bim in multiple myeloma. Neoplasia. 2017;19:772\u201380.","journal-title":"Neoplasia"},{"key":"8559_CR76","first-page":"1551","volume":"8","author":"Z Fang","year":"2018","unstructured":"Fang Z, Wang J, Clark LH, Sun W, Yin Y, Kong W, et al. ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitro. Am J Cancer Res. 2018;8:1551\u201363.","journal-title":"Am J Cancer Res"},{"key":"8559_CR77","doi-asserted-by":"publisher","first-page":"ra17","DOI":"10.1126\/scisignal.aac4380","volume":"9","author":"J Ishizawa","year":"2016","unstructured":"Ishizawa J, Kojima K, Chachad D, Ruvolo P, Ruvolo V, Jacamo RO, et al. ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies. Sci Signal. 2016;9:ra17.","journal-title":"Sci Signal"},{"key":"8559_CR78","doi-asserted-by":"publisher","first-page":"36456","DOI":"10.18632\/oncotarget.5505","volume":"6","author":"G Karpel-Massler","year":"2015","unstructured":"Karpel-Massler G, B\u00e2 M, Shu C, Halatsch M-E, Westhoff M-A, Bruce JN, et al. TIC10\/ONC201 synergizes with Bcl-2\/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo. Oncotarget. 2015;6:36456\u201371.","journal-title":"Oncotarget"},{"key":"8559_CR79","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","volume":"56","author":"L Thorel","year":"2024","unstructured":"Thorel L, Perr\u00e9ard M, Florent R, Divoux J, Coffy S, Vincent A, et al. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology. Exp Mol Med. 2024;56:1531\u201351.","journal-title":"Exp Mol Med"},{"key":"8559_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101939","volume":"44","author":"YK Carmi","year":"2024","unstructured":"Carmi YK, Agbarya A, Khamaisi H, Farah R, Shechtman Y, Korobochka R, et al. Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells. Transl Oncol. 2024;44:101939.","journal-title":"Transl Oncol"},{"key":"8559_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-021-00756-z","volume":"11","author":"N Aide","year":"2021","unstructured":"Aide N, Poulain L, Elie N, Briand M, Giffard F, Blanc-Fournier C, et al. A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers. EJNMMI Res. 2021;11:11.","journal-title":"EJNMMI Res"},{"key":"8559_CR82","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.chembiol.2020.04.002","volume":"27","author":"M Marchesini","year":"2020","unstructured":"Marchesini M, Gherli A, Montanaro A, Patrizi L, Sorrentino C, Pagliaro L, et al. Blockade of oncogenic NOTCH1 with the SERCA inhibitor CAD204520 in T cell acute lymphoblastic leukemia. Cell Chem Biol. 2020;27:678\u20136.e13.","journal-title":"Cell Chem Biol"},{"key":"8559_CR83","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1084\/jem.20151778","volume":"215","author":"G Roti","year":"2018","unstructured":"Roti G, Qi J, Kitara S, Sanchez-Martin M, Saur Conway A, Varca AC, et al. Leukemia-specific delivery of mutant NOTCH1 targeted therapy. J Exp Med. 2018;215:197\u201321.","journal-title":"J Exp Med"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08559-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08559-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08559-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:02:39Z","timestamp":1778155359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08559-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8559"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08559-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6768426\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"416"}}